Brief: Interpace Biosciences Announces Impending Delisting From Nasdaq
17/02/2021 14:40
Feb 17 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES IMPENDING DELISTING FROM
NASDAQ
* INTERPACE BIOSCIENCES INC - HAS APPLIED TO HAVE ITS COMMON
STOCK
QUALIFIED TO TRADE ON OTCQX BEST MARKET
Source text for Eikon: ID:nGNX4qncJP
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million